National Pension Service Has $49.33 Million Stake in Humana Inc. $HUM

National Pension Service increased its position in Humana Inc. (NYSE:HUM) by 2.8% during the third quarter, Holdings Channel.com reports. The firm owned 189,601 shares of the insurance provider’s stock after buying an additional 5,150 shares during the quarter. National Pension Service’s holdings in Humana were worth $49,328,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Trust Inc. increased its position in shares of Humana by 3.6% during the second quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock worth $334,000 after acquiring an additional 48 shares in the last quarter. Private Wealth Management Group LLC boosted its stake in Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 48 shares during the last quarter. Ossiam increased its holdings in Humana by 1.6% during the 2nd quarter. Ossiam now owns 4,375 shares of the insurance provider’s stock worth $1,070,000 after purchasing an additional 71 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in shares of Humana by 15.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 518 shares of the insurance provider’s stock worth $135,000 after purchasing an additional 71 shares during the last quarter. Finally, Signaturefd LLC lifted its holdings in shares of Humana by 4.7% in the third quarter. Signaturefd LLC now owns 1,626 shares of the insurance provider’s stock valued at $423,000 after purchasing an additional 73 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Stock Down 0.8%

Shares of NYSE:HUM opened at $195.15 on Monday. The company has a market cap of $23.47 billion, a price-to-earnings ratio of 18.29, a PEG ratio of 1.61 and a beta of 0.44. Humana Inc. has a one year low of $191.39 and a one year high of $315.35. The firm has a fifty day moving average price of $256.45 and a two-hundred day moving average price of $264.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The business had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.16 EPS. Analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent analyst reports. Bank of America upped their target price on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research note on Friday, October 10th. Truist Financial reduced their price objective on shares of Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $344.00 price objective on shares of Humana in a research note on Tuesday, January 6th. The Goldman Sachs Group cut their target price on Humana from $235.00 to $215.00 and set a “sell” rating on the stock in a research note on Monday, November 24th. Finally, Zacks Research downgraded Humana from a “hold” rating to a “strong sell” rating in a research report on Thursday, January 1st. Eight research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $293.21.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.